Cucurbitacin E inhibits esophageal carcinoma cell proliferation, migration, and invasion by suppressing Rac1 expression through PI3K/AKT/mTOR pathway

Luquan Zhang,Hao Liang,Yanzhong Xin
DOI: https://doi.org/10.1097/cad.0000000000000961
2020-06-11
Abstract:As an oxygenated tetracyclic triterpenoid, <span class="ej-keyword">Cucurbitacin E</span> (CuE) possesses potential antitumor properties in sorts of malignancies. However, its effect on human esophageal carcinoma cells has not been previously unearthed, and the mechanism underlying its anticarcinoma activity remains vague. Hence, this study was arranged to probe the function of CuE on esophageal carcinoma cells and its specific mechanism. Human esophageal carcinoma cells (ECA109 and EC9706) and human normal esophageal epithelial cells (Het-1A) were selected for subsequent experiments. The expression levels of <span class="ej-keyword">Rac1</span> in esophageal carcinoma cells were measured. After transfection of sh-<span class="ej-keyword">Rac1</span> or pCDNA3.1-<span class="ej-keyword">Rac1</span>, esophageal carcinoma cells were exposed to CuE. Then, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay and 5-ethynyl-2'-deoxyuridine staining were utilized for measurement of cell <span class="ej-keyword">proliferation</span> ability, cell scratch assay for inspection of cell <span class="ej-keyword">migration</span> rate, and Transwell for detection of cell <span class="ej-keyword">invasion</span> ability. The phosphorylation levels of protein kinase B and mTOR were analyzed by Western blot. <span class="ej-keyword">Rac1</span> was highly expressed in esophageal carcinoma cells. Transfection of sh-<span class="ej-keyword">Rac1</span> in esophageal carcinoma cells resulted in suppression on cell <span class="ej-keyword">proliferation</span>, <span class="ej-keyword">migration</span>, and <span class="ej-keyword">invasion</span>, as well as downregulated phosphorylation levels of AKT and mammalian target of rapamycin (mTOR) in esophageal carcinoma cells, while transfection of pCDNA3.1-<span class="ej-keyword">Rac1</span> had an opposite effect, implicating that <span class="ej-keyword">Rac1</span> can promote the viability of esophageal carcinoma cells. Esophageal carcinoma cells subjected to CuE treatment had decreased expression of <span class="ej-keyword">Rac1</span>, suppressed cell viability, and decreased phosphorylation levels of AKT and mTOR. Transfection of pCDNA3.1-<span class="ej-keyword">Rac1</span> and CuE treatment in esophageal carcinoma cells enhanced viability of esophageal carcinoma cells and promoted the phosphorylation levels of AKT and mTOR in comparison with cells treated with CuE alone. CuE inhibits <span class="ej-keyword">proliferation</span>, <span class="ej-keyword">invasion</span>, and <span class="ej-keyword">migration</span> of esophageal carcinoma cells via downregulating <span class="ej-keyword">Rac1</span> to block the phosphoinositide 3-kinase/AKT/mTOR pathway.
oncology,pharmacology & pharmacy
What problem does this paper attempt to address?